Moreover, analysis of the CGGA database showed that FAM181A-AS1 expression was significantly higher in patients with WHO stage IV glioma compared to those with WHO stage II/III glioma (Figure 1B). The gene discussed is FAM181A; the disease is central nervous system cancer.